“This is the largest deal we’ve done,” Repertoire Chairman and CEO Torben Straight Nissen told BioWorld. By featuring med-tech coverage within BioWorld, readers gain a more complete perspective of key developments in medical technologies alongside therapeutics all in one place. The final edition of BioWorld MedTech will publish on Jan. 30, 2026, introducing a more streamlined and comprehensive experience for readers starting on Monday, Feb. 2, 2026. All existing BioWorld MedTech subscribers will be automatically transitioned to BioWorld Premium, ensuring continued access to med-tech coverage as part of a broader view of research, clinical development and commercialization. Thank you for being part of the BioWorld MedTech community.